Pexidartinib | m-entrepreneurship.com

Product Name :
Pexidartinib

Search keywords :
Pexidartinib

drugId :
null

Target Vo:
Stem cell growth factor receptor

Target Vo Short Name :
KIT

Moa_Name:
Stem cell growth factor receptor inhibitors

First Approval Country :
United States

First Approval Date Filter:
2019

Origin Company_Name :
Daiichi Sankyo Co Ltd

Active Company_Name :
Barbara Ann Karmanos Cancer Institute

Active Indication_Name:
Giant Cell Tumor of Tendon Sheath

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse 4-1BB/CD137 Antibody (3H3) custom synthesis
SOCS1 Rabbit pAb In stock
CD19 Antibody (YA807): CD19 Antibody (YA807) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD19 (3G7). It can be used for ICC/IF,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts